Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXACILLIN vs OXAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OXACILLIN vs OXAZEPAM: Safety Overview

Metric OXACILLIN OXAZEPAM
Total FAERS Reports 538 12,440
Deaths Reported 89 2,965
Death Rate 16.5% 23.8%
Hospitalizations 254 6,242
Average Patient Age 46.9 yrs 57.3 yrs
% Female Patients 44.9% 58.3%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Eugia US LLC Aphena Pharma Solutions - Tennessee, LLC
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued